Overview / Abstract: |
Even though the COVID-19 pandemic is slowly becoming endemic, there are still certain populations at higher risk of progressing to severe COVID-19 should they become infected with SARS-CoV-2. These include immunocompromised groups, older patients, patients with HIV, disabilities, challenges in social determinants of health, and racial or ethnic minorities. There are treatment considerations for many of these populations, including drug-drug interactions. In this self-directed activity, Drs. Glenn Treisman, Lewis Teperman, Brinda Emu, and Onyema Ogbuagu answer common questions about 10 patient populations at high risk of severe COVID-19. |
Expiration |
Aug 03, 2024 |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Brinda Emu, MD Onyema Ogbuagu, MBBCh, FACP, FIDSA Lewis W. Teperman, MD, FACS Glenn Jordan Treisman, MD, PhD |
Sponsors / Supporters / Grant Providers |
Jointly provided by Partners for Advancing Clinical Education (PACE) and Integritas Communications. This activity is supported by an independent educational grant from Pfizer Inc. |
Keywords / Search Terms |
Integritas Communications COVID-19, special populations, high-risk patients Free CE CME |